Skip to main content
. Author manuscript; available in PMC: 2012 Dec 5.
Published in final edited form as: Mol Pharm. 2011 Nov 1;8(6):2331–2338. doi: 10.1021/mp2002297

Figure 3.

Figure 3

(A) Representative Western blot analyses of MDA-MB-435 cell lysates for MT1-MMP (64 kDa). (B-D) Fluorescent immunostaining of MT1-MMP expression in an MDA-MB-435 tumor section counterstained with (B) DAPI (blue, marks the nucleus), (C) primary antibody for MT1-MMP and (D) their merged images.